This month on Synapse
We are delighted to introduce our Life Sciences Disputes webinar series, in which our experts cover the following key topics: managing cybersecurity risk, court litigation and arbitration, regulatory investigations and disputes, reputation management, and trade secrets.
The first instalment of our Life Sciences Disputes webinar series provides practical tips and advice, discusses key legislation, and shares case studies on how life sciences organisations can mitigate and manage their litigation risk.
Agnieszka Sztoldman discusses a CJEU ruling that liberalises parallel import regulations in Poland, and may in fact fit the purpose of protecting public health and human life.
Judith Krens and Misja Boeken explain the District Court of The Hague's decision on the merits that Fresenius Kabi’s generic pemetrexed tromethamine drug does not infringe Eli Lilly's patent for pemetrexed disodium.
Judith Krens and Misja Boeken report on how the Dutch Inspectorate for Health and Youth Care has issued a new policy on the exemption from authorisation of pharmaceutical preparations made on a "small scale".
